share_log

Louisiana State Employees Retirement System Acquires New Stake in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Louisiana State Employees Retirement System Acquires New Stake in Merit Medical Systems, Inc. (NASDAQ:MMSI)

路易斯安那州雇员退休系统公司收购纳斯达克公司(MMSI)的新股份
Defense World ·  2022/12/31 05:11

Louisiana State Employees Retirement System acquired a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 27,100 shares of the medical instruments supplier's stock, valued at approximately $1,531,000.

根据路易斯安那州雇员退休系统公司提交给美国证券交易委员会的最新表格13F文件,该公司在第三季度收购了Merit Medical Systems,Inc.(微博代码:MMSI-GET Rating)的新股份。该机构投资者购买了27,100股医疗器械供应商的股票,价值约1,531,000美元。

Several other hedge funds have also recently added to or reduced their stakes in MMSI. Eagle Asset Management Inc. raised its stake in Merit Medical Systems by 48.4% in the 2nd quarter. Eagle Asset Management Inc. now owns 712,135 shares of the medical instruments supplier's stock valued at $38,647,000 after purchasing an additional 232,211 shares during the last quarter. Assenagon Asset Management S.A. raised its stake in Merit Medical Systems by 114.2% in the 2nd quarter. Assenagon Asset Management S.A. now owns 264,292 shares of the medical instruments supplier's stock valued at $14,343,000 after purchasing an additional 140,933 shares during the last quarter. Hudson Bay Capital Management LP acquired a new stake in shares of Merit Medical Systems in the 2nd quarter worth $5,201,000. Fuller & Thaler Asset Management Inc. increased its stake in shares of Merit Medical Systems by 13.9% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 725,079 shares of the medical instruments supplier's stock worth $48,232,000 after acquiring an additional 88,251 shares during the last quarter. Finally, ExodusPoint Capital Management LP increased its stake in shares of Merit Medical Systems by 1,457.3% in the 2nd quarter. ExodusPoint Capital Management LP now owns 88,767 shares of the medical instruments supplier's stock worth $4,817,000 after acquiring an additional 83,067 shares during the last quarter. 95.38% of the stock is owned by institutional investors and hedge funds.

其他几家对冲基金最近也增持或减持了MMSI的股份。Eagle Asset Management Inc.在第二季度增持了48.4%的Merit Medical Systems股份。Eagle Asset Management Inc.现在持有这家医疗器械供应商的712,135股股票,价值38,647,000美元,此前该公司在上个季度又购买了232,211股票。Assenagon Asset Management S.A.在第二季度增持了114.2%的Merit Medical Systems股份。Assenagon Asset Management S.A.在上个季度额外购买了140,933股后,现在拥有这家医疗器械供应商264,292股股票,价值14,343,000美元。哈德逊湾资本管理有限公司在第二季度收购了价值5,201,000美元的Merit Medical Systems新股。Fuller&Thaler Asset Management Inc.在第一季度增持了Merit Medical Systems的股票13.9%。富勒资产管理公司(Fuller&Thaler Asset Management Inc.)在上个季度增持了88,251股后,目前持有这家医疗器械供应商725,079股股票,价值48,232,000美元。最后,ExodusPoint Capital Management LP在第二季度将其在Merit Medical Systems的股份增加了1,457.3%。ExodusPoint Capital Management LP在上个季度增持了83,067股后,现在拥有这家医疗器械供应商的88,767股股票,价值4,817,000美元。95.38%的股票由机构投资者和对冲基金持有。

Get
到达
Merit Medical Systems
优点医疗系统
alerts:
警报:

Analyst Ratings Changes

分析师评级发生变化

MMSI has been the subject of a number of recent research reports. TheStreet raised Merit Medical Systems from a "c+" rating to a "b-" rating in a research note on Friday, September 16th. Canaccord Genuity Group downgraded Merit Medical Systems from a "buy" rating to a "hold" rating and cut their target price for the stock from $73.00 to $72.00 in a research note on Tuesday, December 20th. Raymond James raised their target price on Merit Medical Systems from $71.00 to $72.00 and gave the stock an "outperform" rating in a research note on Thursday, October 27th. StockNews.com downgraded Merit Medical Systems from a "strong-buy" rating to a "buy" rating in a research note on Monday, December 26th. Finally, Canaccord Genuity Group raised their target price on Merit Medical Systems from $69.00 to $73.00 in a research note on Monday, November 7th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, Merit Medical Systems presently has an average rating of "Moderate Buy" and a consensus target price of $73.50.

MMSI是最近一些研究报告的主题。华尔街在9月16日星期五的一份研究报告中将Merit医疗系统的评级从“c+”上调至“b-”。在12月20日星期二的一份研究报告中,Canaccel Genuity Group将Merit Medical Systems的评级从买入下调至持有,并将该股的目标价从73.00美元下调至72.00美元。雷蒙德·詹姆斯在10月27日周四的一份研究报告中将Merit Medical Systems的目标价从71.00美元上调至72.00美元,并给予该股“跑赢大盘”的评级。在12月26日周一发布的一份研究报告中,StockNews.com将Merit Medical Systems的评级从“强力买入”下调至“买入”。最后,Canaccel Genuity Group在11月7日星期一的一份研究报告中将Merit Medical Systems的目标价从69.00美元上调至73.00美元。一位分析师对该股的评级为持有,五位分析师对该股的评级为买入。根据MarketBeat.com的数据,Merit Medical Systems目前的平均评级为“中等买入”,共识目标价为73.50美元。

Merit Medical Systems Stock Performance

优点医疗系统股票表现

NASDAQ MMSI opened at $70.62 on Friday. The stock has a market cap of $4.02 billion, a PE ratio of 65.39, a P/E/G ratio of 2.46 and a beta of 1.02. The company has a current ratio of 2.35, a quick ratio of 1.19 and a debt-to-equity ratio of 0.19. Merit Medical Systems, Inc. has a twelve month low of $50.46 and a twelve month high of $76.14. The stock has a fifty day simple moving average of $69.67 and a 200-day simple moving average of $61.35.
纳斯达克MMSI上周五开盘报70.62美元。该股市值为40.2亿美元,市盈率为65.39倍,市盈率为2.46倍,贝塔系数为1.02。该公司的流动比率为2.35,速动比率为1.19,债务权益比率为0.19。优点医疗系统公司的股价为50.46美元的12个月低点和76.14美元的12个月高位。该股的50日简单移动均线为69.67美元,200日简单移动均线为61.35美元。

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last released its quarterly earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 earnings per share for the quarter, topping analysts' consensus estimates of $0.53 by $0.11. The business had revenue of $287.18 million during the quarter, compared to analysts' expectations of $273.03 million. Merit Medical Systems had a return on equity of 14.14% and a net margin of 5.43%. Equities analysts anticipate that Merit Medical Systems, Inc. will post 2.57 earnings per share for the current year.

优点医疗系统公司(纳斯达克代码:MMSI-GET Rating)最近一次发布季度收益报告是在10月26日星期三。这家医疗器械供应商公布本季度每股收益为0.64美元,比分析师普遍预期的0.53美元高出0.11美元。该业务本季度营收为2.8718亿美元,高于分析师预期的2.7303亿美元。优点医疗系统公司的股本回报率为14.14%,净利润率为5.43%。股票分析师预计,Merit Medical Systems,Inc.本年度每股收益将达到2.57美元。

About Merit Medical Systems

关于功德医疗系统公司

(Get Rating)

(获取评级)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

优点医疗系统公司设计、开发、制造和营销用于介入、诊断和治疗程序的一次性医疗产品,主要用于心脏病学、放射学、肿瘤学、危重护理和内窥镜检查。该公司在心血管和内窥镜两个领域开展业务。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Is Kintara Therapeutics A Hidden Gem?
  • Should You Warm up to Generac Stock for the Winter?
  • 免费获取StockNews.com关于Merit Medical Systems(MMSI)的研究报告
  • MarketBeat:回顾一周12/26-12/30
  • 科技狗:是时候咬一口这些股票了
  • 这笔收购会让微软成为熊市买入者吗?
  • 金塔拉治疗公司是一颗隐藏的宝石吗?
  • 你应该热身到Generac股票过冬吗?

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating).

想看看还有哪些对冲基金持有MMSI吗?访问HoldingsChannel.com获取Merit Medical Systems,Inc.(纳斯达克代码:MMSI-GET Rating)的最新13F备案文件和内幕交易信息。

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受新闻和评级的优点医疗系统每日-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Merit Medical Systems和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发